Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02446405
Title Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors University of Sydney
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.